Chemoinformaics analysis of (Z)-3-Hexenoic acid benzyl ester
| Molecular Weight | 204.269 | nRot | 5 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 8 |
| Exact Molecular Weight | 204.115 | nRing | 1 |
| Solubility: LogS | -3.553 | nHRing | 0 |
| Solubility: LogP | 3.588 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 33.9827 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.544 |
| Synth | 1.995 |
| Natural Product Likeliness | 0.603 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.294 |
| MDCK | 0.0000586 |
| BBB | 0.587 |
| PPB | 0.941744 |
| VDSS | 1.971 |
| FU | 0.0822299 |
| CYP1A2-inh | 0.984 |
| CYP1A2-sub | 0.118 |
| CYP2c19-inh | 0.925 |
| CYP2c19-sub | 0.095 |
| CYP2c9-inh | 0.475 |
| CYP2c9-sub | 0.4 |
| CYP2d6-inh | 0.032 |
| CYP2d6-sub | 0.167 |
| CYP3a4-inh | 0.131 |
| CYP3a4-sub | 0.291 |
| CL | 14.54 |
| T12 | 0.871 |
| hERG | 0.064 |
| Ames | 0.09 |
| ROA | 0.057 |
| SkinSen | 0.871 |
| Carcinogencity | 0.589 |
| EI | 0.977 |
| Respiratory | 0.051 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.597487 |